Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €101.87B | 16.8x | 0.41 | €83.61 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.4% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €8.54B | 24.2x | -0.51 | €104 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.65B | 18.3x | 0.89 | €316 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €871.70M | 14.8x | 2.5 | €73.50 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
Medincell | Paris | Healthcare | Pharmaceuticals | €544.97M | €16.43 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.6% Upside | Upgrade to Pro+ | |||
Boiron | Paris | Healthcare | Pharmaceuticals | €387.18M | 34.3x | -0.5 | €22.20 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.1% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | €295.40M | -1.7x | -0.07 | €3.19 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.2% Downside | Upgrade to Pro+ | |
DBV Technologies | Paris | Healthcare | Pharmaceuticals | €228.36M | -1.7x | 0.06 | €1.68 | 7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.6% Downside | Upgrade to Pro+ | |
AB Science | Paris | Healthcare | Pharmaceuticals | €88.89M | -9x | -0.32 | €1.35 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SMAIO | Paris | Healthcare | Pharmaceuticals | €32.34M | -9.6x | 0.04 | €5.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.7% Upside | Upgrade to Pro+ | |
Advicenne | Paris | Healthcare | Pharmaceuticals | €17.18M | -1.7x | -0.14 | €1.40 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nicox | Paris | Healthcare | Pharmaceuticals | €16.82M | €0.22 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Aelis Farma | Paris | Healthcare | Pharmaceuticals | €13.21M | -2.3x | 0.04 | €0.93 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valerio Therapeutics | Paris | Healthcare | Pharmaceuticals | €10.16M | -0.8x | -0.02 | €0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |